Copyright © Inderes 2011 - present. All rights reserved.

Orion

42,78

 

EUR

 

+1,25 %

ORNBV

NASDAQ Helsinki

Biotechnology & Pharmaceuticals

Health Care

13.886 investorer følger denne virksomhed
Sammenligne
+1,25%
-3,97%
-9,35%
+8%
+8,94%
+12,73%
+19,9%
+1,71%
+280,94%

Orion operates in the pharmaceutical industry. The company conducts research and development of human and veterinary drugs, where the main focus is on diseases that affect the nervous system, as well as oncology and respiratory diseases. Today, the company's products are found on a global level, with the largest presence in the Nordic region and the rest of Europe. The company's head office is located in Espoo, Finland.

Læs mere
Markedsværdi
6,04 mia. EUR
Aktieomsætning
20,51 mio. EUR
P/E (adj.) (24e)
19,29
EV/EBIT (adj.) (24e)
15,2
P/B (24e)
6,17
EV/S (24e)
4,04
Udbytteafkast, % (24e)
3,86 %
Coverage
Anbefaling
Akkumulér
Kursmål
47.00 EUR
Opdateret
30.10.2024
Finanskalender
25.2
2025

Årsrapport '24

3.4
2025

Generalforsamling '24

23.4
2025

Delårsrapport Q1'25

Risiko
Business risk
Valuation risk
Lav
Høj
ViserAlle indholdstyper

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.